Amphastar Wants Momenta Drug Standards Info In Patent Suit
By Kelcee Griffis ( April 27, 2017, 3:19 PM EDT) -- Amphastar Pharmaceuticals Inc. told a Massachusetts federal judge on Wednesday that Momenta Pharmaceuticals Inc. should disclose recent communications with the scientific nonprofit that creates enforceable drug standards for the pharmaceutical industry in a patent suit over generic versions of the blood thinner Lovenox....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.